Clinical Chemistry analyzer
Blood lead testing
Magellan Diagnostics introduces LeadCare Ultra, a quantitative, FDA (510k) cleared, bench-top solution for laboratory blood lead testing. The six-channel analyzer allows stat testing with results in just three minutes, and batches at a rate of 90 tests per hour. Its closed-system design requires no set-up or routine maintenance costs, and features electronic calibration, a barcode scanner, QC tracking, and LIS connectivity. The LeadCare Ultra system is based on technology that has been in clinical use for more than two decades. Magellan also offers a portable, CLIA-waived blood lead analyzer, the LeadCare II. Magellan Diagnostics, Inc.
Flexible tissue processor
Rabbit monoclonal antibody for IVD use
Liquid amies collection and transport systems
Determine HIV 1/2 Ag/Ab Combo
Alere has received U.S. Food and Drug Administration (FDA) approval of its pre-market application (PMA) to market Alere Determine(tm) HIV 1/2 Ag/Ab Combo in the United States. Alere Determine(tm) HIV-1/2 Ag/Ab Combo is the first and only FDA-approved rapid point-of-care test for the simultaneous and separate qualitative detection of HIV-1/2 antibodies and free H IV-1 p24 antigen, which can appear just days after infection and prior to HIV-1/2 antibodies. Alere